McKesson Corporation (MCK) Strong Quarter Spurs Analyst Confidence
McKesson Corporation (NYSE:MCK) is one of the best blue-chip stocks to buy now.
Mckesson Corp (MCK)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,288,763 | $995,620,968 | +5% | 0.63% |
| 2. | AQR Capital Management Cliff Asness | 829,038 | $630,988,935 | -4% | 0.4% |
| 3. | SurgoCap Partners Mala Gaonkar | 452,261 | $349,389,713 | +69% | 9.71% |
| 4. | Farallon Capital Thomas Steyer | 327,100 | $252,697,834 | +4% | 1.03% |
| 5. | GLG Partners Noam Gottesman | 305,492 | $236,004,790 | +28% | 0.41% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $144.52 | 692 | $100,006.66 | 6,843 | 2016-11-30 | Filing | |
| $136.36 | 100 | $13,635.52 | 2,005 | 2016-11-02 | Filing | |
| $136.35 | 900 | $122,715.00 | 1,905 | 2016-11-02 | Filing | |
| $156.21 | 1,000 | $156,211.40 | 1,000 | 2016-02-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $861.63 | 329 | $283,476.27 | 328 | 2025-11-07 | Filing | |
| $705.63 | 11,930 | $8,418,165.90 | 4,012 | 2025-08-22 | Filing | |
| $677.76 | 11,930 | $8,085,676.80 | 15,942 | 2025-08-15 | Filing | |
| $663.67 | 329 | $218,347.43 | 657 | 2025-08-08 | Filing | |
| $708.09 | 19,371 | $13,716,411.39 | 27,872 | 2025-07-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,031,610 | $9,294,899,990 | 0.14% | |
| 2. | 11,295,439 | $8,726,178,540 | 0.15% | |
| 3. | 5,750,519 | $4,447,109,903 | 0.15% | |
| 4. | 3,924,282 | $3,031,664,816 | 0.94% | |
| 5. | 2,928,757 | $2,262,581,276 | 0.12% |
News See All
13 Best Blue Chip Stocks to Buy Now
Blue-chip stocks are well-positioned to emerge as the ultimate winners amid the Trump tariffs and a shift in monetary policy.
McKesson Corporation (NYSE:MCK) Q2 2026 Earnings Call Transcript
Operator: Welcome to McKesson's Second Quarter Fiscal 2026 Earnings Conference Call. Please be advised that today's conference is being recorded.
McKesson Corporation (MCK): A Bull Case Theory
We came across a bullish thesis on McKesson Corporation on Value investing subreddit by entropybender. In this article, we will summarize the bulls’ thesis on MCK.
McKesson Corporation (NYSE:MCK) Q1 2026 Earnings Call Transcript
Operator: Welcome to McKesson's First Quarter Fiscal 2026 Earnings Conference Call. Please be advised that today's conference is being recorded.
McKesson Corporation (MCK): A Bull Case Theory
We came across a bullish thesis on McKesson Corporation on The Buyside Guy’s Substack. In this article, we will summarize the bulls’ thesis on MCK.
Is McKesson (MCK) an Overlooked Dividend Stock in the Pharma Sector for 2025?
In its fourth-quarter 2025 earnings announcement, the company revealed plans to spin off its Medical-Surgical Solutions segment into a separate entity, referred to as “NewCo.” Management emphasized...
14 Best Pharma Dividend Stocks to Buy in 2025
The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 pandemic, expanded collaborations across the value chain, and ongoing changes in...
McKesson Corporation (MCK): If It Was Down, I'd Say "Fill Her Up," Says Jim Cramer
McKesson Corporation (NYSE:MCK) is one of the largest healthcare services providers in America.
Jim Cramer's Fresh 14 Stocks & Thoughts About Market Performance
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed a JPMorgan note suggesting that its clients expected President Trump to be more accommodating when it came to market concerns...